InsidersTradesSigma
Track the 佐力药业 stock price and the full directors' dealings record of the company, a listed issuer based in China. Shares are quoted on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 佐力药业 has published 3 reports. Market capitalisation: €10bn. The latest transaction was disclosed on 22 April 2024 (Sale). Among the most active insiders: 陆秀梅. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Zalijia Pharmaceutical es una empresa del sector de la salud y farmacéutico, que cotiza en el mercado XSHE. Se centra en el desarrollo y la producción de medicamentos innovadores.